Company Profile

Inogen Stock Price, News & Analysis

Ticker:
INGN
Exchange:
NASDAQ
Sector:
Biopharma
Location:
United States

Stock performance

5.90 USD (-1.99%)

Close

Last updated: August 11, 2026

165M USD

Market cap

Why the stock is moving

As of Aug 11, 2026, INGN closed down 1.99% at $5.90. No new same-company headline was identified in the current news window.

Company overview

Home Respiratory Care

Inogen develops and commercializes respiratory products for patients receiving care at home. Its portfolio is designed to support mobility, independence and long-term disease management.

Portable Oxygen Concentrators

The company's Inogen One systems generate concentrated oxygen from ambient air, reducing dependence on delivered oxygen tanks. Products reach patients through direct-to-consumer sales, home-care providers and international distributors. Inogen is expanding into obstructive-sleep-apnea care through products including the Aurora full-face CPAP mask, broadening its respiratory platform beyond oxygen therapy.

Future catalysts

  • Presentation of the 90-day Aurora CPAP mask study at SLEEP 2026.

Recent news

  1. 01
  2. 02
  3. 03
  4. 04
  5. 05

Similar stocks

Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.

Frequently Asked Questions

What is the current stock price of Inogen (INGN)?

Inogen (INGN) most recently closed at 5.90 USD, a -1.99% move versus the previous session.

What is the market cap of Inogen (INGN)?

Inogen currently has a market capitalization of 165M USD on BioPharmSignal.

What does Inogen do?

Home Respiratory Care Inogen develops and commercializes respiratory products for patients receiving care at home. Its portfolio is designed to support mobility, independence and long-term disease management. Portable Oxygen Concentrators The company's Inogen One systems generate concentrated oxygen from ambient air, reducing dependence on delivered oxygen...

On which exchange is INGN stock listed?

Inogen (INGN) is associated with NASDAQ, United States, Biopharma.

What is Home?

Home Respiratory Care Inogen develops and commercializes respiratory products for patients receiving care at home.

Which conditions is Inogen targeting with Home?

Inogen is associated with respiratory disease based on its company overview and current catalyst commentary.

How does Inogen describe recent progress with Home?

Presentation of the 90-day Aurora CPAP mask study at SLEEP 2026.

What is Respiratory?

Home Respiratory Care Inogen develops and commercializes respiratory products for patients receiving care at home.